Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
17.9M
-
Shares change
-
-1.21M
-
Total reported value, excl. options
-
$9.48M
-
Value change
-
-$814K
-
Put/Call ratio
-
0.29
-
Number of buys
-
16
-
Number of sells
-
-19
-
Price
-
$0.53
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q4 2022
62 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q4 2022.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.9M shares
of 129M outstanding shares and own 13.86% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.7M shares), BlackRock Inc. (3.46M shares), Laurion Capital Management LP (2.23M shares), D. E. Shaw & Co., Inc. (1.47M shares), GEODE CAPITAL MANAGEMENT, LLC (1.22M shares), RENAISSANCE TECHNOLOGIES LLC (845K shares), MILLENNIUM MANAGEMENT LLC (564K shares), STATE STREET CORP (481K shares), NORTHERN TRUST CORP (220K shares), and SABBY MANAGEMENT, LLC (204K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.